Straumann Holding AGXSWX:STMN -0.42%98 PS Ratio is 6.52 as of Jun. 27, 2026, which is 28% below its 10-year median of 9.10. GuruFocus rates XSWX:STMN with a GF Score™ of 98/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 76.99% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Straumann Holding AG's share price is CHF106.35.
Straumann Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF16.32. Hence, Straumann Holding AG's PS Ratio for today is 6.52.
Warning Sign:
Straumann Holding AG stock PS Ratio (=6.52) is close to 1-year high of 6.97.
The historical rank and industry rank for Straumann Holding AG's PS Ratio or its related term are showing as below:
XSWX:STMN'
s PS Ratio Range Over the Past 10 Years
Min: 4.64 Med: 9.1 Max: 22.89
Current: 6.52
During the past 13 years, Straumann Holding AG's highest PS Ratio was 22.89. The lowest was 4.64. And the median was 9.10.
XSWX:STMN's PS Ratio is ranked worse than 76.99% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.86
vs XSWX:STMN: 6.52
Straumann Holding AG revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Straumann Holding AG was 4.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 12.70% per year.
During the past 13 years, Straumann Holding AG's highest 3-Year average Revenue per Share Growth Rate was 22.50% per year. The lowest was -3.90% per year. And the median was 10.10% per year.
Back to Basics: PS Ratio
Straumann Holding AG (XSWX:STMN) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Straumann Holding AG PS Ratio Related Terms
Straumann Holding AG PS Ratio Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Straumann Holding AG's Share Price of today is CHF106.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Straumann Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF16.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Straumann Holding AG (XSWX:STMN) has a PS Ratio of 6.52 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Straumann Holding AG and its competitors. This is 28% below median its historical median of 9.10. Over the past decade, Straumann Holding AG's PS Ratio has ranged from 4.64 to 22.89. According to the industry distribution chart, Straumann Holding AG ranks #619 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 77%.
Is Straumann Holding AG's PS Ratio too high?
Straumann Holding AG's current PS Ratio of 6.52 is 28% below median its 10-year median of 9.10. Over the past 10 years, this metric has ranged from a low of 4.64 to a high of 22.89. The Medical Devices & Instruments industry median PS Ratio is 2.86. Straumann Holding AG's value of 6.52 is 128% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #619 out of 804 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Straumann Holding AG has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #619 out of 804 companies for PS Ratio. This places Straumann Holding AG in the lower half of its industry. The industry median PS Ratio is 2.86. Straumann Holding AG's value of 6.52 is 128% above this benchmark. Historically, Straumann Holding AG's own PS Ratio has ranged from 4.64 to 22.89 over the past decade. While the company's 10-year median is 9.10 vs. the industry median of 2.86, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current PS Ratio of 6.52 is 128% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current PS Ratio is 6.52, which is 28% below median its own 10-year median of 9.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.35 — trading 22.3% below its estimated fair value. The current PS Ratio is 6.52, which is 28% below median its 10-year median of 9.10 and 128% above the Medical Devices & Instruments industry median of 2.86. Straumann Holding AG's overall GF Score™ is 98/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current PS Ratio is 6.52 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.35 is trading 22.3% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
PS Ratio: 6.52 (28% below median its 10-year median of 9.10)
GF Value™: CHF136.92 vs. price of CHF106.35 (22.3% below fair value)
Industry Position: 128% above the Medical Devices & Instruments median (#619 of 804)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
98GF Score
Get the complete analysis for XSWX:STMN
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
